services

Masseter Botox

drerfanrahmani » Services » Masseter Botox
Masseter Botox is a botulinum toxin treatment used to reduce excessive activity and, over time, the bulk of the masseter muscles at the angles of the jaw. In appropriately selected patients, it may create a softer and less square lower-face contour and may also reduce clenching or grinding associated with bruxism. The cosmetic slimming effect develops gradually because reduction in muscle volume takes longer than the initial reduction in muscle activity.

What Is the Masseter Muscle?

The masseter is a powerful rectangular muscle of mastication extending from the zygomatic arch to the angle and lateral surface of the mandibular ramus. Its main function is to elevate the mandible and clench the teeth; it also assists with protrusion and side-to-side grinding movements. The supplied chapter describes superficial, middle and deep masseter layers. These layers are more distinct superiorly and converge inferiorly, which explains why much of the palpable muscle bulk is concentrated closer to the jawline.

What Is Masseter Hypertrophy?

Masseter hypertrophy means enlargement of one or both masseter muscles. It can produce a wide, square or heavy lower face, accentuate the mandibular angles, or create asymmetry. The source notes that it is commonly observed between ages 20 and 40 and may be purely aesthetic or associated with pain, bruxism and functional symptoms.
  • A naturally strong or genetically bulky masseter
  • Repeated jaw clenching or teeth grinding
  • Habitual gum chewing or other repetitive chewing behaviors
  • Functional overuse of the muscle
  • Asymmetry between the right and left masseters

How Can Masseter Botox Slim the Lower Face?

Botulinum toxin temporarily reduces neuromuscular activity. When a hypertrophic masseter is repeatedly less active, its volume can gradually decrease. For patients whose lower-face width is substantially caused by muscle rather than bone or fat, this can create a softer, less angular and more oval facial shape. The chapter reports visible masseter volume reduction within about one month, with peak reduction typically around three months. Aesthetic benefit may persist for approximately six to nine months, although individual response varies.

Masseter Botox for a Square Jaw

A square jaw is not always caused by the masseter. Mandibular bone shape, facial fat, jowling and other structural factors may contribute. During assessment, the patient is typically asked to clench firmly while the clinician palpates the muscle. If a large dynamic masseter bulge is an important contributor, neuromodulator treatment may be appropriate. If facial width is primarily skeletal, reducing the muscle cannot reproduce the effect of changing the underlying mandible. Accurate diagnosis is therefore essential before promising facial slimming.

What Is Bruxism?

Bruxism is involuntary or unconscious clenching or grinding of the teeth. It can occur while awake or during sleep. The chapter associates bruxism with abnormal tooth wear, damaged dental restorations, jaw dysfunction, myofascial pain, headache and masseter hypertrophy. Its causes may be multifactorial. The source discusses family history, bite or structural factors, emotional stress, neurologic factors and habitual masseter engagement among possible contributors.

Can Masseter Botox Help Bruxism?

The chapter reviews randomized and controlled studies reporting reductions in bruxism episodes and/or associated pain after botulinum toxin treatment of the masseters. The intended functional effect is to reduce excessive clenching power rather than completely disable normal chewing. Because bruxism may have dental, sleep-related, behavioral or other causes, botulinum toxin should be considered within a broader clinical assessment rather than as a universal cure for every patient who grinds their teeth.

Aesthetic Treatment vs. Bruxism Treatment

The treatment objective changes the plan. Facial slimming aims to reduce muscle bulk and reshape the lower face, whereas symptomatic treatment focuses more on excessive contraction, clenching and pain. The chapter notes that dosing requirements may therefore differ according to muscle size and whether the main goal is aesthetic or symptomatic.

How Is the Masseter Assessed?

  • Facial shape at rest and during clenching
  • Right-left masseter symmetry
  • Muscle thickness and bulge pattern
  • Location of the anterior and posterior muscle borders
  • Lower-face skin laxity and existing jowling
  • History of grinding, clenching, headache or jaw pain
  • Dental wear or restoration problems where relevant
  • Whether facial width is muscular, skeletal, fatty or mixed

The source emphasizes mapping nearby anatomy because the masseter lies close to the parotid gland and duct, facial vessels, marginal mandibular nerve and the risorius muscle.

Why Injection Precision Matters

The risorius and other lower-face muscles are especially important when treating the masseter for cosmetic purposes. Unwanted toxin spread can alter the smile or facial expression. The parotid gland is also nearby, and inadvertent treatment of salivary tissue may contribute to dry mouth. These anatomical relationships are why a tailored treatment zone is safer than using a generic injection template.

When Will I See Facial Slimming?

Reduction in clenching activity can occur before visible facial slimming. According to the chapter, measurable contraction changes have been observed within weeks, while visible masseter volume reduction may become apparent within one month and commonly peaks at around three months.

For this reason, judging a facial-slimming result too early can be misleading. Follow-up photography at standardized angles can be useful when the main goal is contour change.

How Long Does Masseter Botox Last?

The supplied chapter reports that aesthetic effects can last up to approximately nine months and recommends treatment intervals in the range of six to nine months for maintenance of aesthetic results. Symptomatic effects and pain relief have variable durations between patients.

Possible Side Effects and Complications

The chapter describes masseter botulinum toxin treatment as generally well tolerated in the published clinical literature, but careful technique and patient selection remain important.

  • Temporary injection-site pain, swelling or bruising
  • Headache
  • Temporary muscle weakness
  • Temporary muscle weakness
  • Asymmetric smile if toxin affects the risorius
  • Altered facial expression if adjacent smile muscles are affected
  • Dry mouth if the parotid region is inadvertently affected
  • Paradoxical masseter bulging during chewing
  • Potential worsening of jowling in susceptible patients

What Is Paradoxical Masseter Bulging?

Paradoxical bulging is an uncommon visible bulge that can appear during chewing after treatment. The chapter describes this ‘Popeye muscle’ phenomenon as potentially related to uneven treatment of different masseter layers. Understanding the layered anatomy and distributing treatment appropriately can help reduce this risk.

Can Masseter Botox Make Jowls Worse?

In some older patients with a large masseter and significant lower-face skin laxity, reducing the muscle can remove some of the posterior soft-tissue support that previously masked laxity. The source specifically warns that worsening jowling has been reported more often in patients over 50 with significant lower-face laxity. This makes pre-treatment assessment of skin quality and jowls particularly important.

Masseter Botox vs. Jawline Filler

These treatments address different anatomy. Masseter Botox reduces excessive muscle activity and may narrow a muscular lower face. Jawline filler adds structural volume and projection. A patient with a wide muscular jaw may benefit from masseter treatment, while a patient with weak mandibular definition may require structural enhancement instead. Some patients have mixed concerns and need a staged plan.

Masseter Botox vs. Facial Fat Reduction

Botulinum toxin does not dissolve facial fat. If lower-face width is primarily caused by fat rather than muscle, masseter treatment may provide little narrowing. Likewise, treatment cannot change the underlying width of the mandibular bone.

Who May Be a Good Candidate?

  • Prominent masseters during clenching
  • Muscular square-jaw appearance
  • Lower-face asymmetry related to masseter size
  • Bruxism or excessive clenching where masseter hyperactivity is clinically relevant
  • Realistic expectations about gradual facial slimming
  • Adequate lower-face skin support without severe laxity

Who Needs Extra Caution?

The source supports careful selection in patients with substantial lower-face laxity or jowling because reduction in masseter bulk may worsen tissue redundancy. A full medical and aesthetic assessment is also required to identify contraindications to botulinum toxin and to distinguish muscular symptoms from dental, temporomandibular or other causes.

Masseter Botox in Abu Dhabi - Frequently Asked Questions

It can narrow the lower face when masseter muscle bulk is a major cause of facial width. The effect is gradual and is different from fat reduction or changing the jaw bone.
Muscle activity can reduce earlier, but visible facial slimming may take about a month and commonly peaks around three months.
The chapter reports aesthetic effects lasting approximately six to nine months in many patients.
Published studies reviewed in the chapter report reductions in bruxism activity and/or associated pain in selected patients.
Treatment is intended to reduce excessive masseter activity, not eliminate normal chewing. Temporary difficulty with very hard foods can occur.
It may reduce pain associated with excessive masseter activity or bruxism in selected patients, but jaw pain has multiple possible causes and requires assessment.
No. It reduces muscle activity and bulk; it does not alter mandibular bone width.
Rarely, toxin spread into nearby muscles such as the risorius can affect the smile. Accurate anatomy and injection placement reduce this risk.
It is an uncommon focal masseter bulge seen during chewing after treatment, potentially related to uneven effects across muscle layers.
Yes, in susceptible patients—particularly those with significant lower-face laxity—reducing a large masseter may make existing jowling more noticeable.
No. Neuromodulator effects are temporary, although repeated treatments may produce longer-term changes in muscle bulk in some patients.
Not exactly. Masseter treatment targets the chewing muscle for bulk or hyperactivity; other jawline neuromodulator techniques may target different muscles such as the platysma.
No. It is used aesthetically for lower-face contouring and has also been studied for functional problems such as bruxism and associated pain.
Not necessarily. Muscle bulk, facial proportions, desired shape and functional goals differ between individuals, so treatment should be individualized.
Because a broad lower face can be caused by muscle, bone, fat, laxity or a combination. Treatment is most predictable when the dominant cause is correctly identified.

Leave a Reply

Your email address will not be published. Required fields are marked *

DR Erfan Rahmani Logo
call now